Changes and Clinical Significance of PIVKA-II in Hepatitis E Patients

• Main Authors: Youran Chen (Author), Yanyan Yang (Author), Shanshan Li (Author), Minghao Lin (Author), Xueting Xie (Author), Huifang Shi (Author), Yuchun Jiang (Author), Sijie Zheng (Author), Hui Shao (Author), Naibin Yang (Author), Mingqin Lu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Increased protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels had been widely reported in patients with hepatocellular carcinoma (HCC) and chronic hepatitis. However, the role of PIVKA-II in hepatitis E is unclear. The aim of this study was to clarify the changes related with PIV...